115 research outputs found

    Synthesis of titanate nanofibers co-sensitized with ZnS and Bi2S3 nanocrystallites and their application on pollutants removal

    Full text link
    The synthesis of nanocomposite materials combining titanate nanofibers (TNF) with nanocrystalline ZnS and Bi2S3 semiconductors is described in this work. The TNF were produced via hydrothermal synthesis and sensitized with the semiconductor nanoparticles, through a single-source precursor decomposition method. ZnS and Bi2S3 nanoparticles were successfully grown onto the TNF's surface and Bi2S3-ZnS/TNF nanocomposite materials with different layouts were obtained using either a layer-by-layer or a co-sensitization approach. The samples' photocatalytic performance was first evaluated through the production of the hydroxyl radical using terephthalic acid as probe molecule. All the tested samples show photocatalytic ability for the production of this oxidizing species. Afterwards, the samples were investigated for the removal of methylene blue. The nanocomposite materials with best adsorption ability for the organic dye were the ZnS/TNF and Bi2S3ZnS/TNF. The removal of the methylene blue was systematically studied, and the most promising results were obtained considering a sequential combination of an adsorption-photocatalytic degradation process using the Bi2S3ZnS/TNF powder as a highly adsorbent and photocatalyst material.Comment: 26 pages, 10 figure

    Manifestation of triplet superconductivity in superconductor-ferromagnet structures

    Full text link
    We study proximity effects in a multilayered superconductor/ferromagnet (S/F) structure with arbitrary relative directions of the magnetization M{\bf M}. If the magnetizations of different layers are collinear the superconducting condensate function induced in the F layers has only a singlet component and a triplet one with a zero projection of the total magnetic moment of the Cooper pairs on the M{\bf M} direction. In this case the condensate penetrates the F layers over a short length ξJ\xi_J determined by the exchange energy JJ. If the magnetizations M{\bf M} are not collinear the triplet component has, in addition to the zero projection, the projections ±1\pm1. The latter component is even in the momentum, odd in the Matsubara frequency and penetrates the F layers over a long distance that increases with decreasing temperature and does not depend on JJ (spin-orbit interaction limits this length). If the thickness of the F layers is much larger than ξJ\xi_J, the Josephson coupling between neighboring S layers is provided only by the triplet component, so that a new type of superconductivity arises in the transverse direction of the structure. The Josephson critical current is positive (negative) for the case of a positive (negative) chirality of the vector M{\bf M}. We demonstrate that this type of the triplet condensate can be detected also by measuring the density of states in F/S/F structures.Comment: 14 pages; 9 figures. Final version, to be published in Phys. Rev.

    An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

    Get PDF
    For a decade, The Cancer Genome Atlas (TCGA) program collected clinicopathologic annotation data along with multi-platform molecular profiles of more than 11,000 human tumors across 33 different cancer types. TCGA clinical data contain key features representing the democratized nature of the data collection process. To ensure proper use of this large clinical dataset associated with genomic features, we developed a standardized dataset named the TCGA Pan-Cancer Clinical Data Resource (TCGA-CDR), which includes four major clinical outcome endpoints. In addition to detailing major challenges and statistical limitations encountered during the effort of integrating the acquired clinical data, we present a summary that includes endpoint usage recommendations for each cancer type. These TCGA-CDR findings appear to be consistent with cancer genomics studies independent of the TCGA effort and provide opportunities for investigating cancer biology using clinical correlates at an unprecedented scale. Analysis of clinicopathologic annotations for over 11,000 cancer patients in the TCGA program leads to the generation of TCGA Clinical Data Resource, which provides recommendations of clinical outcome endpoint usage for 33 cancer types

    A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.

    Get PDF
    In cancer, the primary tumour's organ of origin and histopathology are the strongest determinants of its clinical behaviour, but in 3% of cases a patient presents with a metastatic tumour and no obvious primary. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, we train a deep learning classifier to predict cancer type based on patterns of somatic passenger mutations detected in whole genome sequencing (WGS) of 2606 tumours representing 24 common cancer types produced by the PCAWG Consortium. Our classifier achieves an accuracy of 91% on held-out tumor samples and 88% and 83% respectively on independent primary and metastatic samples, roughly double the accuracy of trained pathologists when presented with a metastatic tumour without knowledge of the primary. Surprisingly, adding information on driver mutations reduced accuracy. Our results have clinical applicability, underscore how patterns of somatic passenger mutations encode the state of the cell of origin, and can inform future strategies to detect the source of circulating tumour DNA

    Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

    Get PDF
    Gene fusions represent an important class of somatic alterations in cancer. We systematically investigated fusions in 9,624 tumors across 33 cancer types using multiple fusion calling tools. We identified a total of 25,664 fusions, with a 63% validation rate. Integration of gene expression, copy number, and fusion annotation data revealed that fusions involving oncogenes tend to exhibit increased expression, whereas fusions involving tumor suppressors have the opposite effect. For fusions involving kinases, we found 1,275 with an intact kinase domain, the proportion of which varied significantly across cancer types. Our study suggests that fusions drive the development of 16.5% of cancer cases and function as the sole driver in more than 1% of them. Finally, we identified druggable fusions involving genes such as TMPRSS2, RET, FGFR3, ALK, and ESR1 in 6.0% of cases, and we predicted immunogenic peptides, suggesting that fusions may provide leads for targeted drug and immune therapy

    IMPLEMENTASI PEMBERIAN GANTI KERUGIAN LAYANAN PAKET DI PT TIKI JALUR NUGRAHA EKAKURIR (JNE) CABANG SURAKARTA DITINJAU DARI UNDANG-UNDANG NOMOR 38 TAHUN 2009 TENTANG POS

    Get PDF
    ABSTRAK Yusuf Bintang Syaifinuha, E0012414. 2016. IMPLEMENTASI PEMBERIAN GANTI KERUGIAN LAYANAN PAKET DI PT TIKI JALUR NUGRAHA EKAKURIR (JNE) CABANG SURAKARTA DITINJAU DARI UNDANG-UNDANG NOMOR 38 TAHUN 2009 TENTANG POS. Fakultas Hukum Universitas Sebelas Maret Surakarata. Penelitian ini bertujuan untuk mengetahui implementasi pemberian ganti kerugian di PT Tiki Jalur Nugraha Ekakurir (JNE) Cabang Surakarta ditinjau dari UU Pos dan untuk mengetahui cara penyelesaian sengketa yang timbul dari implementasi pemberian ganti kerugian di PT Tiki Jalur Nugraha Ekakurir (JNE) Cabang Surakarta. Metode penelitian yang digunakan dalam penelitian ini adalah deskriptif kualitatif. Jenis penelitian ini adalah penelitian empiris. Data yang digunakan terdiri dari dua data yaitu data primer dan data sekunder. Teknik pengumpulan data adalah dengan metode wawancara dan studi pustaka. Berdasarkan hasil analisis penelitian, dapat diambil kesimpulan bahwa implementasi pemberian ganti kerugian di JNE kurang sesuai dengan Pasal 28 UU Pos karena jenis ganti kerugian hanya untuk kehilangan kiriman dan kerusakan isi kiriman. Pengirim yang mengajukan klaim ganti kerugian harus memenuhi syarat administrasi yang telah ditetapkan oleh JNE. Nilai ganti kerugian yang diberikan JNE adalah 10 kali biaya pengiriman atau sesuai harga barang yang hilang dan/atau rusak jika menggunakan asuransi. JNE memilih upaya hukum diluar pengadilan (nonlitigasi) berupa negosiasi dalam menyelesaikan sengketa yang terjadi dalam implementasi pemberian ganti kerugian. Kata kunci :Perjanjian, Wanprestasi, Implementasi ganti kerugian

    Global perspectives on observing ocean boundary current systems

    Get PDF
    Ocean boundary current systems are key components of the climate system, are home to highly productive ecosystems, and have numerous societal impacts. Establishment of a global network of boundary current observing systems is a critical part of ongoing development of the Global Ocean Observing System. The characteristics of boundary current systems are reviewed, focusing on scientific and societal motivations for sustained observing. Techniques currently used to observe boundary current systems are reviewed, followed by a census of the current state of boundary current observing systems globally. Next steps in the development of boundary current observing systems are considered, leading to several specific recommendations

    Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Get PDF
    Stromal tumor-infiltrating lymphocytes (sTILs) are a potential predictive biomarker for immunotherapy response in metastatic triple-negative breast cancer (TNBC). To incorporate sTILs into clinical trials and diagnostics, reliable assessment is essential. In this review, we propose a new concept, namely the implementation of a risk-management framework that enables the use of sTILs as a stratification factor in clinical trials. We present the design of a biomarker risk-mitigation workflow that can be applied to any biomarker incorporation in clinical trials. We demonstrate the implementation of this concept using sTILs as an integral biomarker in a single-center phase II immunotherapy trial for metastatic TNBC (TONIC trial, NCT02499367), using this workflow to mitigate risks of suboptimal inclusion of sTILs in this specific trial. In this review, we demonstrate that a web-based scoring platform can mitigate potential risk factors when including sTILs in clinical trials, and we argue that this framework can be applied for any future biomarker-driven clinical trial setting
    corecore